Cipla has informed about a Press Release dated August 11, 2015 titled ‘Cipla announces a new respiratory inhaler: Synchrobreathe (SB), a state-of-the-art breath-actuated inhaler which will bring relief to millions of patients with Obstructive Airway Disease (OAD, asthma and COPD)’.
The above information is a part of company’s filings submitted to BSE.
